Announcements Trials
Browse Landscape

Phase

Phase 2 8Phase 3 4Phase 2/3 2

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2NETWORK 2INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Colorectal Neoplasms 1Anus Neoplasms 1

Interventions

Docetaxel 7Radiotherapy 6Vincristine 5Etoposide 5Cyclophosphamide 5Cisplatin 5Specimen Handling 4Paclitaxel 4Magnetic Resonance Spectroscopy 4Gemcitabine 4Doxorubicin 4Carboplatin 4Capecitabine 4pembrolizumab 3dexamethasone acetate 3dexamethasone 21-phosphate 3auricularum 3Prednisone 3Oxaliplatin 3Methotrexate 3Leucovorin 3Fluorouracil 3Dexamethasone 3Cytarabine 3Calcium Dobesilate 3Surgical Procedures, Operative 2Ramucirumab 2Radiation 2Pemetrexed 2Mitomycin 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2/3 × NETWORK × Mitomycin × Clear all
NCT00068744 2012-09-24

Radiation Therapy, Mitomycin, and Either Fluorouracil or Cisplatin in Treating Patients With Locally Advanced Anal Cancer

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2/3 Terminated
88 enrolled
Gastrointestinal

Anus Neoplasms

NCT00294359 2007-08-22

The MAX Study: Mitomycin C, Avastin and Xeloda in Patients With Untreated Metastatic Colorectal Cancer

Australasian Gastro-Intestinal Trials Group

Phase 2/3 Completed
333 enrolled
Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡